Medidata, the leading global provider of cloud-based solutions for clinical research in life sciences, today announced a strategic collaboration with Garmin International Inc.
Medidata announced a strategic collaboration with Garmin International Inc. to integrate Garmin’s vívofit activity tracker with the Medidata Clinical Cloud®. The goal is to allow its customers to make use of mobile health (mHealth) devices with the potential to enhance patient engagement, data quality and operational efficiencies in clinical trials.
Garmin’s vívofit measures steps taken, distance, calories burned and hours slept, using a water-resistant, wrist-worn device and is being used by Medidata to capture patient data in clinical trials.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.